Published in Genet Vaccines Ther on September 19, 2007
Role of the feline immunodeficiency virus L-domain in the presence or absence of Gag processing: involvement of ubiquitin and Nedd4-2s ligase in viral egress. J Cell Physiol (2009) 0.92
Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein. J Virol (2012) 0.92
Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virus. J Virol (2010) 0.81
A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections. J Virol (2012) 0.80
A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts. BMC Biotechnol (2009) 0.77
A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis. Biomed Res Int (2013) 0.75
Genetic Modification of T Cells. Biomedicines (2016) 0.75
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol (2006) 5.58
Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol (1999) 5.35
Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol (2005) 4.59
Dendritic cell immunotherapy: mapping the way. Nat Med (2004) 4.28
How retroviruses select their genomes. Nat Rev Microbiol (2005) 2.99
Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med (1998) 2.58
Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J Exp Med (2005) 2.10
Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol (1999) 1.58
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther (2003) 1.54
Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood (2004) 1.53
Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. J Immunol (2005) 1.39
Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol Ther (2000) 1.30
VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther (2000) 1.28
FIV Vectors. Methods Mol Biol (2003) 1.26
Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. J Biol Chem (2005) 1.20
Integration site choice of a feline immunodeficiency virus vector. J Virol (2006) 1.20
Mapping the encapsidation determinants of feline immunodeficiency virus. J Virol (2002) 1.18
Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity. J Virol (1999) 1.18
Identification of a central DNA flap in feline immunodeficiency virus. J Virol (2001) 1.10
Surface-engineering of lentiviral vectors. J Gene Med (2004) 0.99
Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterization. Virology (2002) 0.97
A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors. Gene Ther (2001) 0.97
Immunotherapy via dendritic cells. Adv Exp Med Biol (2005) 0.97
FIV: from lentivirus to lentivector. J Gene Med (2004) 0.96
Sequences within the gag gene of feline immunodeficiency virus (FIV) are important for efficient RNA encapsidation. Virus Res (2003) 0.93
Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. J Mol Biol (2002) 0.93
Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo. Viral Immunol (2006) 0.92
Gene delivery by lentivirus vectors an overview. Methods Mol Biol (2004) 0.92
Downstream processing of oncoretroviral and lentiviral gene therapy vectors. Biotechnol Adv (2006) 0.91
Relative activity of the feline immunodeficiency virus promoter in feline and primate cell lines. Microbes Infect (2005) 0.90
HIV nuclear import: What's the flap? Nat Med (2000) 0.89
Complexation with chondroitin sulfate C and Polybrene rapidly purifies retrovirus from inhibitors of transduction and substantially enhances gene transfer. Biotechnol Bioeng (2006) 0.87
Study of receptors for vesicular stomatitis virus in vertebrate and invertebrate cells. Microbiologica (1986) 0.86
Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses. J Virol (2001) 0.86
Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Mol Ther (2002) 0.86
Current development of lentiviral-mediated gene transfer. Drug News Perspect (2005) 0.84
AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens. J Virol (2006) 0.83
Viral determinants of integration site preferences of simian immunodeficiency virus-based vectors. J Virol (2006) 0.82
FIV vector systems. Somat Cell Mol Genet (2001) 0.80
Lentiviral vector-transduced dendritic cells induce specific T cell response in a nonhuman primate model. Hum Gene Ther (2005) 0.78
Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination. Gene Ther (2005) 0.77
Adenovirus-mediated transgene-engineered dendritic cell vaccine of cancer. Curr Gene Ther (2005) 0.77
Is gene therapy a good therapeutic approach for HIV-positive patients? Genet Vaccines Ther (2007) 0.76
Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy. J Clin Microbiol (2003) 2.04
Human bocavirus in Italian patients with respiratory diseases. J Clin Virol (2007) 1.80
TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. J Virol (2003) 1.58
Viral vectors: a look back and ahead on gene transfer technology. New Microbiol (2013) 1.25
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol (2011) 1.11
Involvement of the fadD33 gene in the growth of Mycobacterium tuberculosis in the liver of BALB/c mice. Microbiology (2002) 1.08
Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution. J Clin Virol (2010) 1.08
Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9. Virology (2009) 1.04
TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases. J Virol (2003) 1.04
Human anelloviruses and the central nervous system. Rev Med Virol (2010) 1.03
Relationships between total plasma load of torquetenovirus (TTV) and TTV genogroups carried. J Clin Microbiol (2005) 1.02
Small Anellovirus in hepatitis C patients and healthy controls. Emerg Infect Dis (2006) 1.02
Multiple restrictions of human immunodeficiency virus type 1 in feline cells. J Virol (2007) 1.00
Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection. Virology (2002) 0.99
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS. Retrovirology (2007) 0.95
Mapping the domains of CD134 as a functional receptor for feline immunodeficiency virus. J Virol (2006) 0.94
Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein. J Virol (2012) 0.92
Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein. J Virol (2003) 0.91
Associations between nasal torquetenovirus load and spirometric indices in children with asthma. J Infect Dis (2005) 0.91
Correlation between Torque tenovirus infection and serum levels of eosinophil cationic protein in children hospitalized for acute respiratory diseases. J Infect Dis (2004) 0.89
Generation of feline dendritic cells derived from peripheral blood monocytes for in vivo use. Clin Diagn Lab Immunol (2005) 0.89
Supportive care and not only palliative care in the route of cancer patients. Support Care Cancer (2012) 0.88
Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine. J Med Virol (2005) 0.85
Genetic and phylogenetic analyses of HIV-1 corroborate the transmission link hypothesis. J Clin Virol (2004) 0.84
A dormant internal ribosome entry site controls translation of feline immunodeficiency virus. J Virol (2008) 0.84
The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry. Virology (2004) 0.84
Evaluation of underreporting tuberculosis in Central Italy by means of record linkage. BMC Public Health (2012) 0.83
AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens. J Virol (2006) 0.83
In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients. Intervirology (2008) 0.82
Torque teno virus viremia load size in patients with selected congenital defects of innate immunity. Clin Vaccine Immunol (2011) 0.82
Torque Teno Virus: any pathological role in liver transplanted patients? Transpl Int (2008) 0.82
Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus. Clin Vaccine Immunol (2008) 0.81
Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity. Clin Vaccine Immunol (2007) 0.81
High torquetenovirus loads are correlated with bronchiectasis and peripheral airflow limitation in children. Pediatr Infect Dis J (2006) 0.81
Changes In CD8+57+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremia. Transplantation (2008) 0.81
Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virus. J Virol (2010) 0.81
Retroinverso analogue of the antiviral octapeptide C8 inhibits feline immunodeficiency virus in serum. J Med Chem (2003) 0.80
Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env. J Virol (2005) 0.80
Role of hematopoietic cells in the maintenance of chronic human torquetenovirus plasma viremia. J Virol (2010) 0.80
Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein. Virology (2004) 0.80
A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections. J Virol (2012) 0.80
Identification of a human immunodominant T-cell epitope of mycobacterium tuberculosis antigen PPE44. BMC Microbiol (2011) 0.80
Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1. Curr HIV Res (2008) 0.80
Physicochemical characterization of a peptide deriving from the glycoprotein gp36 of the feline immunodeficiency virus and its lipoylated analogue in micellar systems. Biochim Biophys Acta (2006) 0.79
Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus. Chembiochem (2006) 0.79
Feline immunodeficiency virus vector as a tool for preventative strategies against human breast cancer. Vet Immunol Immunopathol (2009) 0.79
Torquetenovirus infection and ciliary dysmotility in children with recurrent pneumonia. Pediatr Infect Dis J (2008) 0.79
Immunotherapy with internally inactivated virus loaded dendritic cells boosts cellular immunity but does not affect feline immunodeficiency virus infection course. Retrovirology (2008) 0.79
Relationship of TT virus and Helicobacter pylori infections in gastric tissues of patients with gastritis. J Med Virol (2003) 0.78
Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood. Clin Diagn Lab Immunol (2005) 0.78
Role of Env in resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV strain as determined by using a chimeric virus. J Virol (2007) 0.78
Feline immunodeficiency virus plasma load reduction by a retroinverso octapeptide reproducing the Trp-rich motif of the transmembrane glycoprotein. Antivir Ther (2005) 0.78
A novel method for producing target cells and assessing cytotoxic T lymphocyte activity in outbred hosts. BMC Biotechnol (2009) 0.77
Rapid increase in total torquetenovirus (TTV) plasma viremia load reveals an apparently transient superinfection by a TTV of a novel group 2 genotype. J Clin Microbiol (2006) 0.77
A new fluorimetric assay to measure cytotoxic T-lymphocyte activity against feline immunodeficiency virus envelope glycoprotein. Vet Immunol Immunopathol (2008) 0.76
Evolution of two amino acid positions governing broad neutralization resistance in a strain of feline immunodeficiency virus over 7 years of persistence in cats. Clin Diagn Lab Immunol (2003) 0.75
A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis. Biomed Res Int (2013) 0.75
Novel approaches to vaccination against the feline immunodeficiency virus. Vet Immunol Immunopathol (2009) 0.75
Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification. Transfusion (2006) 0.75
Is torquetenovirus a potential cause of liver damage in children? J Infect (2005) 0.75
Intracellular detection of interleukin 17 and other cytokines in human bronchoalveolar lavage fluid: a first assessment. Immunol Lett (2011) 0.75
Maria Petrocini Ferretti, the first female surgeon in Florence, Italy. Arch Surg (2011) 0.75